Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2024

Mutant specific inhibitors

Taking aim at the undruggable: Mutant-specific KRAS inhibitors, insights and perspectives

Date

27 Feb 2024

Session

Mutant specific inhibitors

Topics

Clinical Research;  Targeted Therapy

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Melissa Johnson

Authors

M.L. Johnson

Author affiliations

  • Lung Cancer Research, Sarah Cannon Research Institute-Cancer Centre, 37203 - Nashville/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Presenter: All Speakers

Session: Mutant specific inhibitors

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.